U.S. Metals and Mining Stock News

NYSE:GD
NYSE:GDAerospace & Defense

General Dynamics NightDragon Deal Targets Edge In Government Cyber And AI

General Dynamics' GDIT unit has formed a partnership with cybersecurity investment firm NightDragon. The collaboration focuses on bringing commercial artificial intelligence, cybersecurity, and autonomy tools into U.S. government programs. The agreement is intended to speed up government access to emerging security technologies through GDIT's federal customer base. General Dynamics (NYSE:GD) is moving to deepen its role in government technology integration with this GDIT NightDragon...
NYSEAM:ELMD
NYSEAM:ELMDMedical Equipment

Electromed (ELMD) Margin Improvement Reinforces Bullish Earnings Narrative In Q3 2026

Electromed (ELMD) just posted Q3 2026 results with revenue of US$18.6 million and basic EPS of US$0.37, alongside trailing twelve month revenue of US$71.8 million and EPS of US$1.22 that sit against a 41.1% earnings growth rate over the past year. Over recent quarters the company has seen revenue move from US$15.7 million and EPS of US$0.22 in Q3 2025 to US$18.6 million and EPS of US$0.37 in Q3 2026, with trailing net profit margin at 14.1% compared with 11.7% a year earlier. This frames a...
NYSE:B
NYSE:BMetals and Mining

Is Barrick Mining (NYSE:B) Share Price Strength Still Supported By Valuation Models

If you are wondering whether Barrick Mining's current share price offers genuine value or just reflects excitement, the recent performance gives you plenty to think about. The stock recently closed at US$44.87, with returns of 7.9% over 7 days, 4.3% over 30 days, 1.8% year to date, 160.6% over 1 year, 161.2% over 3 years and 111.2% over 5 years. Recent coverage around Barrick Mining has focused on its position in the global materials sector and how investors are reacting to that exposure...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Weakness

How Amneal Pharmaceuticals Stock Has Been Trading Recently Amneal Pharmaceuticals (AMRX) has been on many investors' radars after a period of mixed share performance, with the stock down over the past week, month, and past 3 months despite a strong 1 year total return. See our latest analysis for Amneal Pharmaceuticals. Recent trading has been choppy, with the share price down over the past week and quarter, yet the 1 year and multi year total shareholder returns remain strong. This suggests...
NasdaqGS:DIOD
NasdaqGS:DIODSemiconductor

Diodes Board Shift Raises Questions On Capital Allocation And Growth Focus

Diodes Incorporated (NasdaqGS:DIOD) announced the retirement of longtime Chairman Dr. Keh-Shew Lu after more than 25 years with the company. The board elected Angie Chen Button as the new Chairwoman of the Board, marking a significant leadership change at Diodes. This transition closes a chapter in which Diodes evolved from a mid-sized business into a global semiconductor company. Diodes focuses on semiconductor products that sit behind many everyday electronics, with exposure to...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

GitLab Restructuring For Agentic AI Era Tests Execution And Valuation

GitLab (NasdaqGS:GTLB) has announced a major global restructuring and workforce reduction aimed at repositioning the company for what it calls the agentic AI era. The plan includes country exits, a flatter management structure, and a shift to smaller autonomous teams focused on AI driven software development. GitLab intends to reinvest cost savings from the restructuring into AI infrastructure and an AI centric engineering operating model referred to internally as Act 2. The company has...
NYSE:DAN
NYSE:DANAuto Components

Is It Too Late To Consider Dana (DAN) After A 108% One Year Surge?

If you are wondering whether Dana's share price still offers value after a strong run, it helps to step back and look at what the current market price might be implying about the business. The stock has pulled back over the last week and month, declining 3.7% over 7 days and 6.5% over 30 days, yet it is still up 37.4% year to date and 108.2% over the past year. Recent coverage around Dana has focused on its role in the Auto Components sector and how investors are reacting to that...
NYSE:FICO
NYSE:FICOSoftware

Is There Now An Opportunity In Fair Isaac (FICO) After A 50% One-Year Slump?

For readers wondering whether Fair Isaac, at around US$1,064 per share, is now a bargain or still richly priced, this article walks through what the numbers indicate about the stock's value. The share price has been relatively flat over the last 7 days, edging down 0.2%. It has risen 6.4% over the past month while still sitting well below its levels from earlier in the year, with the stock down 35.2% year to date and 49.9% over the last 12 months. These moves come as investors reassess Fair...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

A Look At Mercury Systems (MRCY) Valuation After Earnings Show Higher Sales And A Smaller Net Loss

Mercury Systems (MRCY) has drawn fresh attention after reporting third quarter and nine month results to March 27, 2026, with higher sales and a sharply reduced net loss compared with a year earlier. See our latest analysis for Mercury Systems. The latest results appear to have reinforced a recovery story in the stock, with a 30 day share price return of 12.09% and a 1 year total shareholder return of 106.11%, suggesting momentum has been building over time. If these results have you looking...
NYSE:ACM
NYSE:ACMConstruction

Aecom (ACM) Q2 EPS Record Reinforces Bullish Margin Expansion Narrative

AECOM's Q2 2026 earnings snapshot AECOM (ACM) has released its Q2 2026 results, reporting revenue of US$3.8 billion and basic EPS of US$1.43, alongside trailing 12 month net income from continuing operations of US$631.3 million. Over recent quarters, the company has seen quarterly revenue move between US$3.8 billion and US$4.2 billion, while basic EPS has ranged from US$0.99 to US$1.43, giving investors a clear read on how earnings track against a trailing 12 month EPS of US$4.82. With a...
NYSE:JBI
NYSE:JBIBuilding

Janus International Group Q1 EPS Collapse Tests Bullish Margin Expansion Narrative

Janus International Group (JBI) has reported Q1 2026 revenue of US$222.7 million with basic EPS of about US$0.00, alongside trailing twelve month revenue of US$896.4 million and EPS of US$0.31, against a backdrop of trailing net profit margin at 4.8% compared with 5.4% a year earlier. Over the past year, revenue has moved from US$963.8 million to US$896.4 million on a trailing basis as EPS shifted from US$0.49 to US$0.31. Investors are weighing forecast earnings growth of about 15.1% a year...
NasdaqGS:XEL
NasdaqGS:XELElectric Utilities

Assessing Xcel Energy (XEL) Valuation After Q1 Earnings, Guidance Reaffirmation And New Google Data Center Agreement

Xcel Energy (XEL) is in focus after reporting first quarter 2026 earnings, reaffirming its full year EPS guidance of $4.04 to $4.16 and signing a new Google data center power agreement. See our latest analysis for Xcel Energy. Recent news, including the Google data center agreement, Q1 2026 earnings and a planned US$4.3b follow on equity offering, comes as Xcel Energy’s share price return has gained 7% year to date. The 1 year total shareholder return sits at 19.82% and the 3 year total...
NasdaqGS:CCCC
NasdaqGS:CCCCBiotechs

C4 Therapeutics (CCCC) Q1 Loss Of US$25.1 Million Reinforces Profitability Concerns

C4 Therapeutics (CCCC) has opened 2026 with Q1 revenue of US$6.2 million and a basic EPS loss of US$0.20, alongside a trailing twelve month revenue base of US$34.9 million and a net loss of US$103.8 million, setting a clear tone for how the market will read the latest update. Over recent quarters the company has seen revenue move between US$5.2 million in Q4 2024 and US$11.2 million in Q3 2025, while quarterly basic EPS has ranged from a loss of US$0.18 to a loss of US$0.49. This print keeps...
NYSE:SMR
NYSE:SMRElectrical

South Korea Deal Highlights NuScale’s International And Non Electric Expansion

South Korea has agreed to invest in NuScale Power's small modular reactor program, with plans for an initial SMR plant in the Uljin region. Korean companies including Doosan Enerbility and Samsung C&T are involved in the collaboration, tying NuScale into South Korea's wider nuclear supply chain. NuScale is also expanding its industrial and European presence through partnerships with Framatome and Ebara Elliott Energy. NuScale Power (NYSE:SMR) is drawing fresh attention as South Korea backs...
NasdaqGS:HTZ
NasdaqGS:HTZTransportation

A Look At Hertz Global Holdings (HTZ) Valuation After Earnings Beat And New Partnerships

Earnings beat and partnerships put Hertz Global Holdings (HTZ) in focus Hertz Global Holdings (HTZ) is back on investors’ radar after first quarter earnings revenue came in ahead of expectations, paired with reduced net losses and a cluster of new partnership announcements. For the quarter ended March 31, 2026, Hertz reported sales of US$2,004 million compared with US$1,813 million a year earlier. The company recorded a net loss of US$333 million, narrower than the US$443 million loss in the...
NYSE:NRGV
NYSE:NRGVElectrical

A Look At Energy Vault Holdings (NRGV) Valuation After Eskom Deal And Shift Toward Higher‑Margin Projects

Energy Vault Holdings (NRGV) is back in focus after announcing an agreement with Eskom to roll out long duration gravity energy storage systems across Southern Africa, alongside recent earnings and guidance updates. See our latest analysis for Energy Vault Holdings. The Eskom agreement and reaffirmed 2026 revenue guidance have arrived alongside sharp share price momentum, with a 90 day share price return of 90.38% and a very large 1 year total shareholder return, although the 5 year total...
NYSEAM:EPM
NYSEAM:EPMOil and Gas

Evolution Petroleum (EPM) Reports US$8.9 Million Q3 Loss Challenging Bullish Earnings Narratives

Evolution Petroleum (EPM) has just posted a soft Q3 2026, with total revenue of US$20.2 million and a basic EPS loss of US$0.26 alongside a net loss of US$8.9 million, setting a cautious tone for the quarter. The company has seen quarterly revenue move in a tight band between US$20.2 million and US$22.6 million over the past six reported periods, while EPS has swung between a profit of US$0.10 and a loss of US$0.26, leaving investors focused on how consistently the business can translate its...
NYSEAM:STXS
NYSEAM:STXSMedical Equipment

Stereotaxis (STXS) Q1 2026 Loss Near US$6 Million Tests Bullish Margin Narrative

Stereotaxis (STXS) opened Q1 2026 with revenue of US$6.3 million and a net loss of US$6.2 million, equal to an EPS loss of US$0.06, as the stock trades around US$1.85. The company reported quarterly revenue of US$7.5 million in Q1 2025 and US$6.3 million in Q1 2026, while EPS loss moved from US$0.07 to US$0.06 over the same period. On a trailing twelve month basis, EPS loss was US$0.24 on revenue of US$31.2 million. Overall, the update keeps the focus on how revenue growth potential might...
NYSEAM:HYLN
NYSEAM:HYLNElectrical

Hyliion Holdings (HYLN) Q1 Loss Of US$11.7 Million Reinforces Persistent Bearish Narratives

Hyliion Holdings (HYLN) opened Q1 2026 with revenue of US$2.8 million and a basic EPS loss of US$0.07, alongside a net income loss of US$11.7 million, setting a clear tone for how margins are shaping up this year. Over the past year, the company has seen quarterly revenue range from US$0.5 million to US$2.8 million, while basic EPS losses moved between roughly US$0.07 and US$0.10. This gives investors a fuller view of how the top line and per share results are tracking across recent periods...
NYSE:LOW
NYSE:LOWSpecialty Retail

A Look At Lowe’s Companies (LOW) Valuation After The Recent Share Price Pullback

Why Lowe's Companies (LOW) Stock Is Back on Watch Lowe's Companies (LOW) stock has come under pressure recently, with shares down about 11% over the past month and roughly 23% over the past 3 months, putting the home improvement retailer back on many investors’ watchlists. See our latest analysis for Lowe's Companies. That recent 11% decline over the past month and 23% fall over 3 months sit against a 1-year total shareholder return that is down 1.63%. The 3 and 5 year total shareholder...
NYSE:GBTG
NYSE:GBTGHospitality

Global Business Travel Group (GBTG) Q1 Revenue Gain Tests Bullish Profitability Narrative

Global Business Travel Group (GBTG) opened Q1 2026 with revenue of US$840 million and basic EPS of US$0.10, setting a clear marker for how the business is translating its scale into per share earnings. Over the past year, the company has seen quarterly revenue move from US$621 million in Q1 2025 to US$840 million in Q1 2026, while basic EPS has shifted from US$0.16 to US$0.10. This gives investors a data point on how margins are being managed as the top line expands. With trailing 12 month...
NYSE:FUN
NYSE:FUNHospitality

Stronger Q1 Operations and New Leaders Might Change The Case For Investing In Six Flags (FUN)

Six Flags Entertainment recently reported first-quarter 2026 results showing revenue of US$225.63 million, up from US$202.06 million a year earlier, alongside executive changes including the planned departure of CFO Brian Witherow and the appointment of new leaders in marketing, legal, and commercial roles. While the company’s net loss widened to US$268.6 million due in part to impairment charges tied to park sales, management highlighted higher attendance, stronger per-capita spending, and...
NYSE:GE
NYSE:GEAerospace & Defense

Potential Boeing Mega Order Puts GE Aerospace Earnings Power In Focus

Boeing is reported to be preparing a potential record-breaking airplane order that could be announced during an upcoming U.S. presidential trade mission to China. The aircraft order is expected to feature GE Aerospace engines, tying NYSE:GE directly to high-profile negotiations between Washington and Beijing. Alongside this, GE is seeing strong interest in commercial engines and new agreements with major airlines, pointing to a larger shift in its aviation franchise. For investors watching...
NasdaqGS:ARVN
NasdaqGS:ARVNPharmaceuticals

Arvinas (ARVN) Q1 Loss Of US$0.90 Per Share Challenges Bullish Margin Narratives

Arvinas (ARVN) opened Q1 2026 with revenue of US$15.6 million and a basic EPS loss of US$0.90, alongside trailing twelve month revenue of US$89.4 million and a net loss of US$221.3 million. Over recent quarters the company has seen quarterly revenue move from US$188.8 million in Q1 2025 to US$15.6 million in Q1 2026, while basic EPS has shifted from a profit of US$1.14 per share in Q1 2025 to a loss of US$0.90. This sets up a results season in which investors may focus on how margins evolve...